top of page

Through the innovative Healthcare Lab,

Pfizer is looking for startups for global collaboration.

Application closed
Kotva 1

Powered by


Chance to work with Pfizer on a local or global level

Access to technology and business experts

Increasing media visibility of your project

Why to apply

Kotva 2


June 15th 2021 

Open call

October 15th 2021

Application deadline

October 2021

Pre-Selection (video calls with TOP 10 startups)

November 2021

Pfizer Healthcare Lab (the main event)

Kotva 3



Pfizer understands that digital technology is going to have an impact on the way we deliver healthcare in the future. To ensure that we continue to deliver on our commitment to the patients relying on us, we seek innovations from the digital health ecosystem that complement our medicines and lead to the best possible outcome for patients throughout their journey.

Pfizer Healthcare Lab is focused on startups that want to change the world thought their Healthcare solutions. During the development and realization of their business ideas, the participants will receive individual support from Pfizer. The best projects will have a chance to directly cooperate on concrete projects with Pfizer in the Czech republic as well as globally.

Pfizer would like to establish cooperation with startups who have some innovative products or services mainly in these areas:

Disease awareness information

Early detection and better diagnosis

Patience Adherence and Compliance

Pharma & Healthcare in general

Other related ideas

Kotva 4



Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at

  • Facebook Sociální Icon
  • Cvrlikání
  • Cvrlikání
  • LinkedIn Sociální Icon
  • Šedý YouTube Icon
Kotva 5




Pfizer is currently working with a number of startups. One of them is the Danish startup Cortrium, that develops mobile solutions for monitoring the heart rhythm. Through Pfizer Healthcare Hub in Berlin, Cortrium receives support on how to meet the regulatory requirements for market access. The collaboration now aims to develop further joint projects to improve care in the area of cardiovascular diseases in Germany. Cortrium benefits from uncomplicated access to various departments at Pfizer, and from a direct exchange with Pfizer employees in areas such as sales, communication and market access.

Reporting of adverse events.  Patients should always seek the advice of their physician in case of adverse events.

If you wish to report an adverse event associated with the administration of Pfizer-BioNTech COVID-19, you can use the web portal at  ttps:// .

In addition, any adverse event of any Pfizer products can be reported by email to or call 283 004 111. Another option for patients and healthcare professionals is to report adverse events using the form on the website of the State Institute for drug control If you are interested in further information about Pfizer products or related medical or pharmaceutical issues, please write your questions to the e-mail address

bottom of page